University of Cincinnati Medical Center is pleased to share with you Cardiovascular Insights, an educational resource with information on the cutting-edge research, clinical trials, training and innovative treatments that are advancing the field.
Home
- Home
- Home
-
19 OCT 15
-
-
09 SEP 15
Special Video Feature: Cardiovascular Insights
Dr. Richard Becker, Chief of the Division of Cardiovascular Health and Disease; and Director, and Physician-in-Chief, of the University of Cincinnati Heart, Lung and Vascular Institute is joined by Dr. David Feldman, Director of Advanced Myocardial and Circulatory and Director of Clinical Services of the Heart, Lung and Vascular Institute. In this video, they discuss
Read more →-
-
09 SEP 15
Are PCSK9 Inhibitors Potentially Appropriate for Patients With Mixed Hyperlipidemia and High Cardiovascular Risk, Despite Statins?
PCSK9 inhibitors are a new class of drugs, not yet FDA-approved, that have been shown to dramatically lower LDL cholesterol levels. Three clinicians discuss their potential. Video includes comments by Dylan Steen, MD, Department of Internal Medicine, Division of Cardiovascular Health and Disease, and UC Health cardiologist. View the video.
Read more →-
-
09 SEP 15
OPTIDUAL Study Results
Dr. Richard Becker, Chief of the Division of Cardiovascular Health and Disease; and Director, and Physician-in-Chief, of the University of Cincinnati Heart, Lung and Vascular Institute, discusses the supportive results from the OPTIDUAL study and his approach to patients who have had stents implanted. View the video.
Read more →-
-
09 SEP 15
Clinical Commentary on CIRCUS Trial Results
Dr. Richard Becker, Chief of the Division of Cardiovascular Health and Disease; and Director, and Physician-in-Chief, of the University of Cincinnati Heart, Lung and Vascular Institute, commented on phase II results of the CIRCUS trial while recently attending the European Society of Cardiology Congress. View the video.
Read more →-
-
01 SEP 15
-